GABAPENTIN

Product NDC: 72865-252
Requested package NDC: 72865-252-05
11-digit product format: 728650252
Labeler code: 72865
Product ID: 72865-252_702f8307-681f-440d-9f1d-3d26141a914b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: XLCare Pharmaceuticals, Inc.
Application: ANDA214956
Marketing category: ANDA
Marketing start: 2021-05-10
Substance: GABAPENTIN
Active strength: 100 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A214956-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10
A214956-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10
A214956-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A214956-001	AB
A214956-002	AB
A214956-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 105 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 105 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A214956-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214956-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214956-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A214956-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214956-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214956-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: GABAPENTIN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
618c948d-deee-44e2-98f0-e5232171dd50	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
72865-252-05	GABAPENTIN	500 in 1 BOTTLE	CAPSULE	500	3
72865-252-18	GABAPENTIN	180 in 1 BOTTLE	CAPSULE	180	3
72865-252-27	GABAPENTIN	270 in 1 BOTTLE	CAPSULE	270	3
72865-252-90	GABAPENTIN	90 in 1 BOTTLE	CAPSULE	90	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
72865-252-05	EA - Each	72865-252	373b63b1-1141-4e41-82c8-f9eb77d35559	1	2023-12-05
72865-252-18	EA - Each	72865-252	88961d90-80ae-4f7c-886e-de2bbabb11b8	1	2023-12-05
72865-252-27	EA - Each	72865-252	16459db2-738c-4a97-97fa-bb0aa02d3280	1	2023-12-05
72865-252-90	EA - Each	72865-252	74ed2884-da59-40ea-a8ea-560aba0fdfdb	1	2023-12-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72865-252	GABAPENTIN CAPSULE [XLCARE PHARMACEUTICALS, INC.]	1	Current NDC, 4 package rows	20231122_618c948d-deee-44e2-98f0-e5232171dd50.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GABAPENTIN	GABAPENTIN	St. Mary's Medical Park Pharmacy	235a6954-318a-9e3a-e063-6394a90a0e21	2026-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Preferred Pharmaceuticals Inc.	dd0e12c2-1986-4ca3-a809-d703a7542419	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	4aa69d04-6b32-4764-a48b-ef5313dd95d3	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	43a3ec78-8235-4d46-a343-2f9226745a39	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	685553b0-384e-400b-a8ae-612ceece8261	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	7ea0b220-edbb-45eb-aeb3-65283f8489a1	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Northwind Health Company, LLC	47214c7c-ba1b-9107-e063-6294a90a5431	2025-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Redpharm Drug	44f2b497-55b2-864f-e063-6294a90ad6d5	2025-12-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	XLCare Pharmaceuticals, Inc.	618c948d-deee-44e2-98f0-e5232171dd50	2025-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956 ndc (package): 72865-252-05 ndc (product): 72865-252 ndc11 (package): 72865025205
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals, Inc.	200b61d7-6e4c-923d-e063-6294a90a42cf	2025-02-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Bryant Ranch Prepack	35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01	2025-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals,Inc.	2b395a14-0f8e-7f5b-e063-6294a90ab546	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Camber Pharmaceuticals, Inc.	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	2024-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Asclemed USA, Inc.	17a62334-209d-4dc1-867a-e5780196a2ca	2024-11-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	2024-01-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310430	gabapentin 100 MG Oral Capsule	PSN	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310431	gabapentin 300 MG Oral Capsule	PSN	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310432	gabapentin 400 MG Oral Capsule	PSN	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310430	gabapentin 100 MG Oral Capsule	SCD	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310431	gabapentin 300 MG Oral Capsule	SCD	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310432	gabapentin 400 MG Oral Capsule	SCD	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	6
310430	gabapentin 100 MG Oral Capsule	PSN	618c948d-deee-44e2-98f0-e5232171dd50	3
310431	gabapentin 300 MG Oral Capsule	PSN	618c948d-deee-44e2-98f0-e5232171dd50	3
310432	gabapentin 400 MG Oral Capsule	PSN	618c948d-deee-44e2-98f0-e5232171dd50	3
310430	gabapentin 100 MG Oral Capsule	SCD	618c948d-deee-44e2-98f0-e5232171dd50	3
310431	gabapentin 300 MG Oral Capsule	SCD	618c948d-deee-44e2-98f0-e5232171dd50	3
310432	gabapentin 400 MG Oral Capsule	SCD	618c948d-deee-44e2-98f0-e5232171dd50	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
72865-252-05	72865025205	500 CAPSULE in 1 BOTTLE (72865-252-05)	500 capsule	2021-05-10	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GABAPENTIN	XLCare Pharmaceuticals, Inc. \| Ascent Pharmaceuticals, Inc.	2025-08-04	HUMAN PRESCRIPTION DRUG LABEL	3
GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	2024-01-04	HUMAN PRESCRIPTION DRUG LABEL	6